1. Epigenetics in lymphocyte and lymphoma: EZH2 as an easy-to-access therapeutic target?

   • Koji Kato

   Progress in Hematology 22 October 2022 Pages: 819 - 820

2. Biological and clinical significance of epigenetic alterations in B-cell lymphomas

   • Daisuke Ennishi

   Progress in Hematology 08 October 2022 Pages: 821 - 827

   

3. The role of epigenetics in T-cell lymphoma

   • Makoto Yamagishi

   Progress in Hematology Open access 14 October 2022 Pages: 828 - 836

   

4. The pleiotropic roles of EZH2 in T-cell immunity and immunotherapy

   • Ying Wang
   • Tien Bui
   • Yi Zhang

   Progress in Hematology 21 October 2022 Pages: 837 - 845

   

5. Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study

   • Hiroshi Kawabata
   • Takeshi Tamura
   • Study Group

   Original Article Open access 22 July 2022 Pages: 846 - 855

   

6. Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma

   • Rena Shimano
   • Hisashi Yamamoto
   • Tadaaki Ito

   Original Article 17 August 2022 Pages: 856 - 862

   

7. Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin–aldosterone–angiotensin system inhibitors in patients with chronic myelogenous leukemia

   • Mariko Tsuda
   • Akie Hirata
   • Yoshihiro Ogawa

   Original Article 06 August 2022 Pages: 863 - 870

   

8. Bosutinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia: final 3-year follow-up results of a phase 2 study

   • Takaaki Ono
   • Masayuki Hino
   • Naoto Takahashi

   Original Article Open access 13 August 2022 Pages: 871 - 882

   

9. Sorafenib maintenance after hematopoietic stem cell transplantation improves outcome of FLT3–ITD-mutated acute myeloid leukemia

   • Semra Aydin
   • Roberto Passera
   • Alessandro Busca

   Original Article Open access 09 August 2022 Pages: 883 - 891

   

10. Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1

    • Lijie Han
    • Yilu Li
    • Jifeng Yu

    Original Article Open access 28 August 2022 Pages: 892 - 901

    

11. Therapy-related myeloid neoplasms of recipient origin after allogeneic hematopoietic stem cell transplantation for acute leukemia

    • Takumi Hoshino
    • Nahoko Hatsumi
    • Satoru Takada

    Original Article 28 August 2022 Pages: 902 - 910

    

12. Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin’s lymphoma: an open-label, multicenter, dose-escalation phase 1 study

    • Hideki Goto
    • Koji Izutsu
    • Kenichi Ishizawa

    Original Article Open access 15 September 2022 Pages: 911 - 921

    

13. Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience

    • Adrianna Spałek
    • Agata Wieczorkiewicz-Kabut
    • Grzegorz Helbig

    Original Article Open access 16 August 2022 Pages: 922 - 928

    

14. Clinical diagnostic accuracy of respiratory failure in critically ill hematopoietic stem cell transplant patients

    • Reeta Barua
    • Bruno Ferreyro
    • Laveena Munshi

    Original Article 12 August 2022 Pages: 929 - 936

    

15. Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients

    • David Cabrera-Garcia
    • Andrea Miltiades
    • Neil L. Harrison

    Original Article 22 August 2022 Pages: 937 - 946

    

16. Anakinra for the treatment of adult secondary HLH: a retrospective experience

    • Leonard Naymagon

    Original Article 10 August 2022 Pages: 947 - 955

17. A novel RARA–SNX15 fusion in PML–RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1)

    • Kentaro Hirade
    • Shigeru Kusumoto
    • Yukiya Yamamoto

    Case Report 19 July 2022 Pages: 956 - 960

    

18. Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia

    • Takeshi Hagino
    • Tomohiko Sato
    • Sayuri Motomura

    Case Report 19 July 2022 Pages: 961 - 965

    

19. Clinical and microbiological characteristics of bacterial meningitis in umbilical cord blood transplantation recipients

    • Takashi Oyama
    • Kosei Kageyama
    • Shuichi Taniguchi

    Case Report 06 August 2022 Pages: 966 - 972

20. Ultrasonographic monitoring of sinusoidal obstruction syndrome in patients treated with inotuzumab ozogamicin

    • Takahito Iwai
    • Mutsumi Nishida
    • Takanori Teshima

    Letter to the Editor 29 October 2022 Pages: 973 - 975

    

21. Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study

    • Hiroshi Kawabata
    • Takeshi Tamura
    • Study Group

    Correction Open access 08 November 2022 Pages: 976 - 977